With US 10 year bond yields moving back toward multi year highs as inflation worries linger, dependable dividend income looks more attractive than ever. Cash in the bank may feel safer, but it does not offer the potential combination of income and business ownership that dividend powerhouses can provide. This article highlights three stocks from our Dividend Powerhouses screener that currently offer 3%+ yields and have a track record of paying investors regularly.

The three dividend stocks that follow are just a sample, and the full Dividend Powerhouses screen surfaced 87 more companies with similarly compelling income stories that are not covered here. To identify and analyze the ideas that best fit your portfolio, head straight into the Dividend Powerhouses (3%+ Yield) screener.

Accenture (ACN)

Overview: Accenture is a Dublin based professional services company that helps large businesses and governments design, build, and run their technology, AI, cloud, and outsourcing operations across sectors from banking and healthcare to energy and consumer goods. It combines higher value consulting with long term managed services, as well as capabilities in automation equipment, robotics, and security focused solutions.

Operations: Accenture generates most of its revenue from its Products segment at about US$22.3b, followed by Health & Public Service at about US$14.9b, Financial Services at about US$13.8b, Communications, Media & Technology at about US$12.4b, and Resources at about US$9.8b.

Market Cap: US$108.2b

Accenture appears in this dividend focused list because it combines a 3.69% yield with a long established role at the heart of enterprise IT, AI and cloud projects for around 9,000 clients. The stock has fallen over the past year and trades on a P/E of 13.9x, below both the US market and its industry. At the same time, return on equity is near 24% and free cash flow supports ongoing dividends and buybacks. The key question for you is whether Accenture’s push into generative and agentic AI, together with US$9b of acquisitions in areas such as OT security and mid market platforms, can offset slower consulting demand and funding risk from a reliance on external borrowing.

Accenture’s 3.69% yield and 13.9x P/E could be masking a bigger story around its AI push and US$9b acquisition program. Get the full context in the analysis report for Accenture

Build your own Accenture style dividend shortlist

Accenture and the other two dividend stocks in this article all surfaced from a single Simply Wall St screener, but the real edge comes from shaping your own filters. Use our flexible Screener to combine dividend yield, valuation, balance sheet and risk filters, or start with any of our curated Investing Ideas.

Medtronic (MDT)

Overview: Medtronic is a global medical technology company based in Ireland that develops and sells devices such as heart pacemakers and defibrillators, spine and brain implants, surgical tools, and diabetes care systems to hospitals, doctors, and patients worldwide.

Operations: Medtronic generates most of its revenue from Cardiovascular at about US$14b, followed by Neuroscience at about US$10.3b, Medical Surgical at about US$8.8b, and Other at about US$3.2b, with sales split fairly evenly between the United States at about US$18.1b and the rest of the world at about US$18.1b.

Market Cap: US$116.8b

Medtronic offers a mix of a 3.11% dividend yield, a long history of annual dividend increases, and exposure to structural healthcare trends such as chronic disease treatment, robotics in the operating room, and AI supported procedures. The product pipeline in cardiac ablation, surgical robotics and diabetes technology is getting regular regulatory momentum. However, recalls, legal cases such as the recent US$88 million hernia mesh verdict, and underperforming segments keep execution risk firmly on the table. Earnings and revenue forecasts point to steady rather than dramatic growth. The key consideration is whether product launches, margin improvement efforts and a planned Diabetes spin off can gradually shift profitability and justify today’s valuation multiples.

Medtronic’s mix of a 3.11% yield, long running dividend growth and a busy pipeline in cardiac ablation, surgical robotics and diabetes tech could be hiding a more interesting setup. See how product launches, margins and the Diabetes spin off all come together in the analysis report for Medtronic

VICI Properties (VICI)

Overview: VICI Properties is a real estate investment trust that owns casino, hotel and leisure properties such as Caesars Palace Las Vegas, MGM Grand and the Venetian, collecting rent from operators through long term triple net leases rather than running the venues itself.

Operations: VICI Properties generates all of its US$4.1b revenue from real estate investment activities in the United States.

Market Cap: US$29.0b

VICI Properties stands out for income investors because it blends a high quality portfolio of landmark experiential real estate with inflation linked, triple net leases that support cash flow visibility and dividend potential. It is still trading at a discount to some estimates of fair value and analyst price targets. Recent deals such as the Golden Entertainment sale leaseback, Carambola Beach Resort redevelopment with Club Med, and new tenants in Canada show how management keeps adding rent streams without relying solely on Las Vegas. The flip side is real concentration in a few big tenants, growing exposure to lending and ongoing use of external funding, which makes the Caesars rent coverage story and balance sheet discipline central to the long term outcome.

VICI Properties’ rent streams, inflation linked leases, and growing roster of non Vegas assets could be masking a very different income profile than many investors assume. See how that thesis stacks up in the analysis report for VICI Properties

Seeking Alternatives Before The Crowd Moves

Fresh stock ideas can move from quiet to crowded quickly. Screens that look under the radar for now may not stay that way. Use this momentum while it matters and get in early.

• Spot companies building real AI cash flows by scanning the 75 profitable AI stocks that aren't just burning cash before the story gets fully priced in and the best entry points are gone.
• Position ahead of potential electrification demand by checking the 9 top copper producer stocks while these producers still sit in fewer portfolios and attention is just starting to build.
• Track companies tied to resilient infrastructure trends with the 40 power grid technology and infrastructure stocks so you are not caught chasing them once the crowd notices the theme.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.